Supernus Pharmaceuticals Newsroom

Numerous Supernus Pharmaceuticals Insiders Sold Stock: Not A Positive Omen

Simply Wall StNov 16 21:12

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 15:13

Supernus Pharmaceuticals to Participate in the 2024 Jefferies London Healthcare Conference

GlobeNewswireNov 14 05:30

Supernus Pharmaceuticals(SUPN.US) Officer Sells US$4.54 Million in Common Stock

$Supernus Pharmaceuticals(SUPN.US)$ Officer Khattar Jack A. sold 125K shares of common stock on Nov 8, 2024 at an average price of $36.29 for a total value of $4.54 million.Source: Announcement What

Futu NewsNov 13 05:19

Form 144 | Supernus Pharmaceuticals(SUPN.US) Officer Proposes to Sell 4.54 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 8, $Supernus Pharmaceuticals(SUPN.US)$ Officer JACK A KHATTAR intends to sell 125K shares of its common stock on Nov 8, with a total market value of approximately $4.54

Futu NewsNov 9 06:05

Supernus Pharmaceuticals Insider Sold Shares Worth $520,480, According to a Recent SEC Filing

MT NewswiresNov 9 05:18

Supernus Pharmaceuticals(SUPN.US) Officer Sells US$4.59 Million in Common Stock

$Supernus Pharmaceuticals(SUPN.US)$ Officer Khattar Jack A. sold 125K shares of common stock on Nov 7, 2024 at an average price of $36.68 for a total value of $4.59 million.Source: Announcement What

Futu NewsNov 9 05:18

Form 144 | Supernus Pharmaceuticals(SUPN.US) Officer Proposes to Sell 4.58 Million in Common Stocks

SEC FILLINGS DISCLOSED/ Nov 7, $Supernus Pharmaceuticals(SUPN.US)$ Officer JACK A KHATTAR intends to sell 125K shares of its common stock on Nov 7, with a total market value of approximately $4.58

Futu NewsNov 8 06:04

Earnings Call: Supernus Pharmaceuticals Reported a Significant Increase in Total Revenue

InvestingNov 6 03:22

Stifel Maintains Supernus Pharmaceuticals(SUPN.US) With Hold Rating, Maintains Target Price $38

Futu NewsNov 5 21:36 · Ratings

Analysts Offer Insights on Healthcare Companies: Supernus Pharmaceuticals (SUPN), Editas Medicine (EDIT) and Revvity (RVTY)

TipRanksNov 5 21:10 · Ratings

Piper Sandler Maintains Supernus Pharmaceuticals(SUPN.US) With Hold Rating, Maintains Target Price $36

Futu NewsNov 5 20:31 · Ratings

Piper Sandler Sticks to Its Hold Rating for Supernus Pharmaceuticals (SUPN)

TipRanksNov 5 19:58 · Ratings

Supernus Pharmaceuticals, Inc. (SUPN) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 5 11:55 · Conference Call

TD Cowen Maintains Supernus Pharmaceuticals(SUPN.US) With Buy Rating, Maintains Target Price $43

Futu NewsNov 5 09:31 · Ratings

Strong Q3 Performance and Promising Future for Supernus Pharmaceuticals Backed by Qelbree's Success

TipRanksNov 5 09:25

Supernus Pharmaceuticals (SUPN) Beats Q3 Earnings and Revenue Estimates

Yahoo FinanceNov 5 08:35

Supernus Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 5 05:24 · Announcements

Supernus Pharmaceuticals GAAP EPS of $0.69, Revenue of $175.69M Beats by $18.39M

Seeking AlphaNov 5 05:15

Supernus Pharmaceuticals | 8-K: Supernus Announces Third Quarter 2024 Financial Results

SECNov 5 05:15